OKYO · OKYO Pharma Limited Ordinary Shares
View on chartInsiders & Stakes
| Gabriele M. Cerrone Director | ▲ Buy | Grant | 10,873,916 Shares held | 7/21/2026 | View profile |
| Gary S. Jacob Chief Executive Officer | ▲ Buy | Grant | 112,420 Shares held | 7/21/2026 | View profile |
| John P. Brancaccio Director | ▲ Buy | Grant | 35,201 Shares held | 7/21/2026 | View profile |
| Rajkumar Patil V Chief Scientific Officer | ▲ Buy | Grant | 20,030 Shares held | 7/27/2026 | View profile |
| Flavio Mantelli CHIEF MEDICAL OFFICER | ▲ Buy | Grant | 20,000 Shares held | 7/21/2026 | View profile |
| Robert John Dempsey CHIEF EXECUTIVE OFFICER | ▲ Buy | Grant | 15,000 Shares held | 7/22/2026 | View profile |
Transaction History
| Rajkumar Patil V | ▲ Buy | Grant | 3,363 | $5K | 7/27/2026 |
| Robert John Dempsey | ▲ Buy | Grant | 15,000 | $23K | 7/22/2026 |
| Gabriele M. Cerrone | ▲ Buy | Grant | 22,500 | $33K | 7/21/2026 |
| Gary S. Jacob | ▲ Buy | Grant | 3,500 | $5K | 7/21/2026 |
| John P. Brancaccio | ▲ Buy | Grant | 5,000 | $7K | 7/21/2026 |
| Flavio Mantelli | ▲ Buy | Grant | 20,000 | $28K | 7/21/2026 |
| Gabriele M. Cerrone | ▲ Buy | Grant | 25,000 | $35K | 7/20/2026 |
| Gabriele M. Cerrone | ▲ Buy | Grant | 300,000 | $516K | 6/8/2026 |
| Gabriele M. Cerrone | ▼ Sell | Other | 70,071 | $105K | 10/27/2023 |
| Gabriele M. Cerrone | ▼ Sell | Other | 499,468 | $749K | 10/23/2023 |
| John P. Brancaccio | ▲ Buy | Open Market | 16,670 | $25K | 9/15/2023 |
| Gabriele M. Cerrone | ▲ Buy | Open Market | 5,800,000 | $441K | 5/19/2022 |
| Gary S. Jacob | ▲ Buy | Open Market | 12,500 | $50K | 5/19/2022 |
| Gabriele M. Cerrone | ▲ Buy | Open Market | 37,500 | $150K | 5/19/2022 |
| Gabriele M. Cerrone | ▲ Buy | Open Market | 1,625,000 | $97K | 5/17/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
OKYO Pharma to Present at Ophthalmic Scientific Conferences
OKYO Pharma announced it will present and participate in several upcoming ophthalmic scientific conferences. The company’s involvement highlights its focus on eye‑care products and may increase visibility among researchers and clinicians. This activity could support interest in OKYO’s pipeline as the firm seeks to advance its ophthalmic therapies.
OKYO Pharma to Present at Ophthalmic Scientific Conferences. OKYO Pharma announced it will present and participate in several upcoming ophthalmic scientific conferences. The company’s involvement highlights its focus on eye‑care products and may increase visibility among researchers and clinicians. This activity could support interest in OKYO’s pipeline as the firm seeks to advance its ophthalmic therapies.